Skip to main content

Published locations for Dalteparin safely used for 12 months to prevent VTE recurrence in cancer patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dalteparin safely used for 12 months to prevent VTE recurrence in cancer patients

User login

  • Reset your password
  • /content/dalteparin-safely-used-12-months-prevent-vte-recurrence-cancer-patients
  • /ehospitalistnews/article/77290/oncology/dalteparin-safely-used-12-months-prevent-vte-recurrence
  • /internalmedicinenews/article/77290/oncology/dalteparin-safely-used-12-months-prevent-vte-recurrence
  • /oncologypractice/article/77290/oncology/dalteparin-safely-used-12-months-prevent-vte-recurrence
  • /hematology-oncology/article/77290/oncology/dalteparin-safely-used-12-months-prevent-vte-recurrence
  • /internalmedicine/article/77290/oncology/dalteparin-safely-used-12-months-prevent-vte-recurrence